Literature DB >> 8931028

Osteoporosis in pregnancy.

W Khovidhunkit1, S Epstein.   

Abstract

Osteoporosis has long been described in pregnant women who developed vertebral fractures in the last trimester or shortly after delivery without underlying disorders. However, this condition appears to be relatively rare and the clinical features, associated metabolic abnormalities and a pathological mechanism have not been fully established. This paper reviews available data on osteoporosis and pregnancy and briefly discusses the relationship between pregnancy and bone mass, calcium homeostasis, systemic skeletal hormones and local factors to help explain the pathophysiology of this unique disorder.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8931028     DOI: 10.1007/bf01623007

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  84 in total

1.  Estrogen status and heredity are major determinants of premenopausal bone mass.

Authors:  R Armamento-Villareal; D T Villareal; L V Avioli; R Civitelli
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

2.  Calcitonin in pregnancy.

Authors:  J Kovarik; W Woloszczuk; W Linkesch; R Pavelka
Journal:  Lancet       Date:  1980-01-26       Impact factor: 79.321

3.  Urinary excretion of calcium in late pregnancy and its relation to creatinine clearance.

Authors:  A T Howarth; D B Morgan; R B Payne
Journal:  Am J Obstet Gynecol       Date:  1977-11-01       Impact factor: 8.661

4.  Markers of type I and type III collagen synthesis in serum as indicators of tissue growth during pregnancy.

Authors:  U Puistola; L Risteli; A Kauppila; M Knip; J Risteli
Journal:  J Clin Endocrinol Metab       Date:  1993-07       Impact factor: 5.958

5.  Determination of insulin-like growth factor-2 in feto-maternal circulation during human pregnancy.

Authors:  T Kubota; S Kamada; M Taguchi; T Aso
Journal:  Acta Endocrinol (Copenh)       Date:  1992-10

6.  Parathyroid hormone-related protein during pregnancy and the perinatal period.

Authors:  K Seki; S Wada; N Nagata; I Nagata
Journal:  Gynecol Obstet Invest       Date:  1994       Impact factor: 2.031

7.  Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease.

Authors:  D D Bikle; E Gee; B Halloran; J G Haddad
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

8.  Changes in calciotrophic hormones and biochemical markers of bone turnover in normal human pregnancy.

Authors:  S J Gallacher; W D Fraser; O J Owens; F J Dryburgh; F C Logue; A Jenkins; J Kennedy; I T Boyle
Journal:  Eur J Endocrinol       Date:  1994-10       Impact factor: 6.664

9.  Changing osteocalcin concentrations during pregnancy and lactation: implications for maternal mineral metabolism.

Authors:  D E Cole; C M Gundberg; L J Stirk; S A Atkinson; D A Hanley; L M Ayer; L S Baldwin
Journal:  J Clin Endocrinol Metab       Date:  1987-08       Impact factor: 5.958

10.  Bone mineral density and bone histomorphometric assessments of postpregnancy osteoporosis: a report of five patients.

Authors:  N Yamamoto; H E Takahashi; T Tanizawa; T Kawashima; N Endo
Journal:  Calcif Tissue Int       Date:  1994-01       Impact factor: 4.333

View more
  21 in total

1.  Bisphosphonates in pregnancy and lactation-associated osteoporosis.

Authors:  S M O'Sullivan; A B Grey; R Singh; I R Reid
Journal:  Osteoporos Int       Date:  2006-04-27       Impact factor: 4.507

2.  Sciatica in the female patient: anatomical considerations, aetiology and review of the literature.

Authors:  Abdul-Wahab T Al-Khodairy; Philippe Bovay; Charles Gobelet
Journal:  Eur Spine J       Date:  2006-04-19       Impact factor: 3.134

3.  Effects of pregnancy and lactation on bone mineral density, and their relation to the serum calcium, phosphorus, calcitonin and parathyroid hormone levels in rats.

Authors:  E Gonen; I Sahin; M Ozbek; E Kovalak; S Yologlu; Y Ates
Journal:  J Endocrinol Invest       Date:  2005-04       Impact factor: 4.256

Review 4.  Presentation and management of osteoporosis presenting in association with pregnancy or lactation.

Authors:  C S Kovacs; S H Ralston
Journal:  Osteoporos Int       Date:  2015-05-05       Impact factor: 4.507

5.  Pregnancy-associated osteoporosis with seven vertebral compression fractures, a case treated with strontium ranelate.

Authors:  Guido Zarattini; Pierangelo Buffoli; Giuliana Isabelli; Marcella Marchese
Journal:  Clin Cases Miner Bone Metab       Date:  2014-05

6.  Effect of teriparatide on pregnancy and lactation-associated osteoporosis with multiple vertebral fractures.

Authors:  Eun Yeong Choe; Je Eun Song; Kyeong Hye Park; Hannah Seok; Eun Jig Lee; Sung-Kil Lim; Yumie Rhee
Journal:  J Bone Miner Metab       Date:  2011-11-23       Impact factor: 2.626

7.  Pregnancy-associated osteoporosis: a case-control study.

Authors:  P Hadji; J Boekhoff; M Hahn; L Hellmeyer; O Hars; I Kyvernitakis
Journal:  Osteoporos Int       Date:  2017-01-10       Impact factor: 4.507

8.  Associations of Parity, Breastfeeding, and Fractures in the Women's Health Observational Study.

Authors:  Carolyn J Crandall; Jingmin Liu; Jane Cauley; Polly A Newcomb; JoAnn E Manson; Mara Z Vitolins; Lisette T Jacobson; Kelli K Rykman; Marcia L Stefanick
Journal:  Obstet Gynecol       Date:  2017-07       Impact factor: 7.661

Review 9.  Osteoporosis in young adults: pathophysiology, diagnosis, and management.

Authors:  S Ferrari; M L Bianchi; J A Eisman; A J Foldes; S Adami; D A Wahl; J J Stepan; M-C de Vernejoul; J-M Kaufman
Journal:  Osteoporos Int       Date:  2012-06-09       Impact factor: 4.507

10.  Successful neridronate therapy in pregnancy-associated osteoporosis.

Authors:  Agostino Gaudio; Carmelo Erio Fiore
Journal:  Clin Cases Miner Bone Metab       Date:  2017-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.